These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 35285220)

  • 41. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L
    Mol Psychiatry; 2019 Dec; 24(12):1868-1883. PubMed ID: 29934549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
    Higgins TM; Goodman DJ; Meyer MC
    Prev Med; 2019 Nov; 128():105786. PubMed ID: 31356827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review.
    Veazie S; Mackey K; Peterson K; Bourne D
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):945-953. PubMed ID: 33145688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
    Cochran G; Bruneau J; Cox N; Gordon AJ
    Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
    Finlay AK; Wong JJ; Ellerbe LS; Rubinsky A; Gupta S; Bowe TR; Schmidt EM; Timko C; Burden JL; Harris AHS
    J Stud Alcohol Drugs; 2018 Nov; 79(6):909-917. PubMed ID: 30573022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
    Hadland SE; Wharam JF; Schuster MA; Zhang F; Samet JH; Larochelle MR
    JAMA Pediatr; 2017 Aug; 171(8):747-755. PubMed ID: 28628701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Medication-Assisted Therapy and Risk of Drug Overdose-Related Hospitalization or Emergency Room Visits in Patients With Opioid Use Disorder.
    Bahrami K; Kuo YF; Digbeu B; Raji MA
    Cureus; 2023 Aug; 15(8):e44167. PubMed ID: 37753052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary care models for treating opioid use disorders: What actually works? A systematic review.
    Lagisetty P; Klasa K; Bush C; Heisler M; Chopra V; Bohnert A
    PLoS One; 2017; 12(10):e0186315. PubMed ID: 29040331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
    Harrison TK; Kornfeld H; Aggarwal AK; Lembke A
    Anesthesiol Clin; 2018 Sep; 36(3):345-359. PubMed ID: 30092933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid use disorder treatment for people experiencing homelessness: A scoping review.
    McLaughlin MF; Li R; Carrero ND; Bain PA; Chatterjee A
    Drug Alcohol Depend; 2021 Jul; 224():108717. PubMed ID: 33985863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
    J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
    [No Abstract]   [Full Text] [Related]  

  • 57. College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
    Andraka-Christou B; Nguyen T; Harris S; Madeira J; Totaram R; Randall-Kosich O; Atkins D; Ford J
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):589-603. PubMed ID: 32543922
    [No Abstract]   [Full Text] [Related]  

  • 58. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic.
    Levin FR; Bisaga A; Sullivan MA; Williams AR; Cates-Wessel K
    Am J Addict; 2016 Dec; 25(8):603-609. PubMed ID: 28051841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What's in a number? Recommending practicality in the DATA 2000 patient limits.
    Barthwell AG; Young JM; Barnes MC; Kulkarni SR
    J Opioid Manag; 2016; 12(4):243-50. PubMed ID: 27575825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective.
    Kinsky S; Houck PR; Mayes K; Loveland D; Daley D; Schuster JM
    J Subst Abuse Treat; 2019 Sep; 104():15-21. PubMed ID: 31370980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.